We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Advanced Oncotherapy Plc | AVO | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.925 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.925 |
| Industry Sector |
|---|
| HEALTH CARE EQUIPMENT & SERVICES |
| Top Posts |
|---|
Posted at 19/1/2024 17:11 by daijavu waterlooO1. You are almost right. The fat lady really is singing her last song. Today's news is that AVO is involved in a bid/takeover situation.Whoever is bidding has AVO over a barrel, so it's unlikely we'll get that much. Under the circumstances, I'd be happy just to get my investment back. Just conjecture, but I wonder if the bidder would want to keep the present management team for a while because they are the 'experts' on LIGHT and are very committed to its success. If the bidder wants to keep them sweet, the deal might include shares in the bidding company as well as cash. It could be a cheap sweetener for the bidder to offer the AVO BoD, as well as for us, if we're included in that aspect of whatever deal is agreed. I wonder if the takeover situation might prompt interest from other potential bidders, leading to a bidding war. That could be interesting. |
Posted at 02/10/2023 08:48 by daijavu There's hope for us yet. If AVO gets through this and there's a clear path to treating the first patient and confirming contracts, the share price could shoot up. |
Posted at 30/9/2023 08:01 by waterloo01 Goodness a long time and way from looking at the building site in Harley St and realizing they were never going to make their initial dates.waterloo01 - 01 Mar 2023 - 18:57:17 - 4971 of 5061 Advanced Oncotherapy (AVO) - formerly CareCapital - AVO twirl, I think you called me 'altruistic' back in 2017 when I suggested all was far from well. Seems the same is true today. Wrong management. Scientists! (and still not open) waterloo01 - 18 Jul 2017 - 18:29:56 - 3522 of 4971 Advanced Oncotherapy (AVO) - formerly CareCapital - AVO Wrong people running this as has been the case for a long time. Good science/bad business. Evans wasn't the 1st red flag but the video of the demolition block, might be the last before the inevitable. To think they raised at £1.00 not that long ago. At least the BOD are also heavily invested. |
Posted at 22/9/2023 08:45 by daijavu My optimistic opinion is that if AVO was going into administration or being bought, we would probably have known by now. Although both might be still be on the table.That leaves the very complicated recapitalisation and recovery plan that was always going to take some time to work through. |
Posted at 15/7/2023 08:28 by daijavu The technology is so far in advance of any other proton beam therapy or radio therapy that it could replace both. AVO's aim is to democratise proton beam therapy by enabling it to be available everywhere.The financial benefits for AVO and LTHs over the years are going to be massive. Just have patience. |
Posted at 05/7/2023 01:06 by daijavu Turning a profit is not the issue here. As long as AVO can generate an income they can keep going without making a profit. The issue is that AVO are not going to generate an income until they sell their first machine. If the BoD can find some way of keeping going until they do then it isn't all over. If the BoD is to be believed, they are close. |
Posted at 20/6/2023 16:01 by daijavu The main thing that keeps me invested is the technology. The main thing that worries me is the BoD.The finances shouldn't bother anyone that much because the technology is so valuable that it should outweigh all other considerations and make AVO a must have company to invest in. Unfortunately, the company and investors have been let down by the BoD so often over the 10 years I've been watching AVO, and in and out of holding the shares, that it's no surprise to me that AVO is now in the situation it's in. I'm waiting until the risk of it going into administration is out of the way before I put any more 'real money' in. |
Posted at 25/5/2023 09:40 by daijavu Mark Plesko of Cosylab who seem to be providing software (control system for a linear accelerator) to Advanced Oncotherapy under a Development Agreement has acquired a stack of free AVO shares, instead of a cash payment, in return for Cosylab delivering the control system to AVO.It seems that Mark Plesko has some faith in the LIGHT system and AVO haven't run out of ideas for keeping the show on the road. |
Posted at 28/3/2023 08:00 by daijavu From how AVO seems to work, they outsource production. They don't make many, or any, components themselves. What they've done up to now is focus on the final assembly. That means that volume ought not to be an issue. Cost could be taken care of by building to order, in which case the purchasers pay the costs of production before they get the machine. AVO have already calculated the selling price and their anticipated profit so I assume the difference is their anticipated cost of production. To get to those figures they must have agreements in place in which the manufacturers of the components provide AVO with their cost of production figures. AVO doesn't have any factories outside of Daresbury because they won't need them.They seem to be planning to be an asset light company, a bit like Apple and Microsoft who don't actually make anything themselves. They outsource everything and get paid a lot of money for selling it all to you and me. I anticipate that AVO might be similar. All they need to do now is get over their present financial difficulties. |
Posted at 26/3/2023 00:49 by daijavu Most of the risk has now been removed and we are close to AVO making money. My main concern is that while LIGHT will undeniably be a success it might not be with AVO.I believe that CERN still holds the rights to LIGHT so that if AVO folds, LIGHT could be licenced by CERN to another company. That would be unfortunate for AVO shareholders and for the scientific members of the AVO BoD who helped develop LIGHT from its early days under CERN a decade or more ago. Before AVO existed. My view is that LIGHT makes AVO different from most other AIM companies and CERN's interest in LIGHT makes it more different still. But what do I know? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
